Loading...
Immunosuppressive agents for dermatological indications in the ongoing COVID‐19 pandemic: Rationalizing use and clinical applicability
The ongoing COVID‐19 epidemic has brought to the fore many concerns related to use of immunosuppressive agents (ISAs) in dermatology. While it is unclear whether the patients on ISAs for skin conditions are more prone to develop COVID‐19, and what impact the ISA may have on the clinical outcome if a...
Na minha lista:
| Udgivet i: | Dermatol Ther |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7280701/ https://ncbi.nlm.nih.gov/pubmed/32436617 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dth.13639 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|